Commission Implementing Decision (EU) 2018/193 of 7 February 2018 authorising laboratories in Brazil and the Russian Federation to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets (notified under document C(2018) 593) (Text with EEA relevance. )

CELEX: 32018D0193
Document type: DEC_IMPL
Sector: Legislation
Date of document: 2018-02-07
In force since: 2018-02-08
Status: In force
ELI: http://data.europa.eu/eli/dec_impl/2018/193/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratories are hereby authorised to perform serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets: (a) TECSA LABORATÓRIOS LTDA Avenida do Contorno, 6226o Funcionários — CEP: 30110-042 Belo Horizonte/MG Brazil (b) Instituto Pasteur Avenida Paulista 393 Cerqueira César São Paulo Brazil (c) Institute of Veterinary Medicine Biotechnology LLC (IBVM) 27 Starovskogo ulitsa Volginski urban locality Petushinski region Vladimir oblast Russian Federation (d) NoviStem LLC 2-oy Roshchinski Proyezd Block 8, Building 5, Office 2 Moscow Russian Federation

Article 2

This Decision is addressed to the Member States.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions